标题
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-03-26
DOI
10.3389/fphar.2019.00282
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics
- (2018) E. Stoffel et al. BRITISH JOURNAL OF DERMATOLOGY
- Paradoxical psoriasis following anti–TNF therapy in ankylosing spondylitis: A population-based cohort study
- (2018) Jung Min Bae et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immune response patterns in non-communicable inflammatory skin diseases
- (2018) K. Eyerich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
- (2018) Curdin Conrad et al. Nature Communications
- Molecular diagnostics of inflammatory disease: New tools and perspectives
- (2017) Natalie Garzorz-Stark et al. EXPERIMENTAL DERMATOLOGY
- TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists
- (2017) Cornelia Deubelbeiss et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective
- (2017) Farah Succaria et al. JOURNAL OF DERMATOLOGY
- Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience
- (2017) Gabrielle Brown et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab
- (2017) Anastasia Skalkou et al. RHEUMATOLOGY INTERNATIONAL
- Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
- (2017) Fabrizio Cantini et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis
- (2016) A. Verwoerd et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?
- (2016) Amelie Decock et al. Journal of Crohns & Colitis
- Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
- (2016) Coline Faivre et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriatic alopecia
- (2015) S. M. C. George et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Reactive Granulomatous Dermatitis
- (2015) Misha Rosenbach et al. DERMATOLOGIC CLINICS
- Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa
- (2015) Marine Delobeau et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Comparison of Molecular Signatures from Multiple Skin Diseases Identifies Mechanisms of Immunopathogenesis
- (2015) Megan S. Inkeles et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TNF-α: a treatment target or cause of sarcoidosis?
- (2015) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis
- (2015) T Cabaleiro et al. PHARMACOGENOMICS JOURNAL
- Cutaneous Drug Eruption with an Interface Dermatitis Pattern due to Anti-tumour Necrosis Factor-alpha Agents: A Relevant Class-effect
- (2014) S Garcovich et al. ACTA DERMATO-VENEREOLOGICA
- Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy
- (2014) Angelo V. Marzano et al. AUTOIMMUNITY
- Classification of inflammatory skin diseases: A proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity
- (2014) Teruki Dainichi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis
- (2014) Masaki Shimizu et al. Modern Rheumatology
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- (2013) Cornelia Tillack et al. GUT
- Paradoxical reaction to etanercept: Development of pyoderma gangraenosum during therapy of psoriasis arthritis
- (2013) Lutz Kowalzick et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases
- (2013) Mª Victoria Hernández et al. ARTHRITIS CARE & RESEARCH
- Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists
- (2012) Edwina Lamrock et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Anti-TNF-Alpha Induced Psoriasiform Eruptions with Severe Scalp Involvement and Alopecia: Report of Five Cases and Review of the Literature
- (2012) F. Osório et al. DERMATOLOGY
- Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis
- (2012) Javier Rueda-Gotor et al. JOINT BONE SPINE
- Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms
- (2012) Mary E. Sherlock et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia
- (2011) Leona A Doyle et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Paradoxical Reactions to Targeted Biological Treatments: A Way to Treat and Trigger?
- (2010) AMG Brunasso et al. ACTA DERMATO-VENEREOLOGICA
- Cutaneous Sarcoidosis Occurring during Anti-TNF-Alpha Treatment: Report of Two Cases
- (2010) F. Dhaille et al. DERMATOLOGY
- Tumor Necrosis Factor-Alpha Antagonist-Induced Sarcoidosis
- (2010) Rochelle Robicheaux Clementine et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
- (2009) Uwe Wollina et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Paradoxical adverse effects of anti-TNF-α treatment: onset or exacerbation of cutaneous disorders
- (2009) Manuelle Viguier et al. Expert Review of Clinical Immunology
- Lichen planus–like eruptions: An emerging side effect of tumor necrosis factor-α antagonists
- (2009) Adam Asarch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study
- (2009) D. Fouache et al. RHEUMATOLOGY
- Sarcoidosis Appearing During Anti-Tumor Necrosis Factor α Therapy: A New “Class Effect” Paradoxical Phenomenon. Two Case Reports and Literature Review
- (2009) Alfonso Massara et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- (2008) Angelique N. Collamer et al. ARTHRITIS AND RHEUMATISM
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
- (2008) Justin M. Ko et al. JOURNAL OF DERMATOLOGICAL TREATMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started